Abstract
Men with chronic obstructive pulmonary disease have reduced endogenous testosterone levels. Little is known, however, about the relationship between pulmonary function and endogenous testosterone levels in a general population. In the present study we have examined the cross-sectional associations between sex hormones measured by immunoassay and pulmonary function assessed with spirometry and oxygen saturation in 2,197 men participating in the fifth Tromsø study. The data were analyzed by univariate correlations, multiple linear regression analyses and analyses of variance and covariance. Total and free testosterone were positively and independently associated with forced vitality capacity, FVC (% of predicted) (P = 0.001 and P = 0.006, respectively) and forced expiratory volume in 1 second, FEV1 (% predicted) (P = 0.033 and P = 0.002, respectively), and men with severe pulmonary obstruction (FEV1 % of predicted < 50) had lower free testosterone levels (P = 0.005). In this cross-sectional data from Tromsø, a reduction in pulmonary function was associated with lower levels of total and free testosterone. We suggest that the reduction of total and free testosterone could be due␣to an alteration of the hypothalamic-pituitary response.
Similar content being viewed by others
Abbreviations
- BMI:
-
body mass index
- COPD:
-
chronic obstructive pulmonary disease
- DHEAS:
-
dehydroepiandrosterone sulphate
- FEV1 :
-
forced expiratory volume in 1 sec
- FSH:
-
follicle stimulating hormone
- FVC:
-
forced vital capacity
- LH:
-
luteinizing hormone
- SHBG:
-
sex hormone-binding globulin
- WC:
-
waist circumference
References
Semple PD, Beastall GH, Watson WS, Hume R. Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci (Lond) 1980; 58: 105–06
Aasebø U, Gyltnes A, Bremnes RM, Aakvaag A, Slørdal L. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy. J Steroid Biochem Molec Biol 1993; 46: 799–03
Kamischke A, Kemper DE, Castel MA, Lüthke M, Rolf C, Behre HM, Magnussen H, Nieschlag E. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11: 41–5
Van Vliet M, Spruit MA, Verleden G, Kasran A, Van Herck E, Pitta F, Bouillion R, Decramer M. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1105–111
Svartberg J, von Mühlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromsø Study. Eur J Epidemiol 2004; 19: 657–63
Casaburi R. Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease. Baillieres Clin Endocrinol Metab 1998; 12: 407–18
Schols AM, Soeters PB, Mostert R. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 1268–274
Ferreira IM, Verreschi IT, Nery LE, Goldstein RS, Zamel N, Brooks D, Jardim JR. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114: 19–8
Svartberg J, Aasebø U, Hjalmarsen A, Sundsfjord J, Jorde R. Testosterone treatment improves body composition and sexual function in men with COPD in a 6-month randomized controlled trial. Respir Med 2004; 98: 906–13
Svartberg J, Midtby M, Bønaa KH, Sundsfjord J, Joakimsen RM, Jorde R. Associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromsø Study. Eur J Endocrinol 2003; 149: 145–52
Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994; 79: 1310–316
English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci 2001; 100: 661–65
Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–672
Standardization of spirometry, 1994 update: American Thoracic Society. Am J Respir Dis 1991; 143: 516–12
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community of steele and coal. official statement of the European respiratory society. Eur Respir J Suppl 1993; 16: 5–0
GOLD. Global Initiative for Chronic Obstructive Lung Disease. Workshop Report: Global Strategy for the Diagnosis, Management and Prevention of COPD. Available at: www.goldcopd.com. Accessed November 22, 2006
Semple PD, Beastall GH, Watson WS, Hume R. Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981; 36: 605–09
Shaarawy M, Mahmoud KZ. Endocrine profile and semen characteristics in male smokers. Fertil Steril 1982; 38: 255–57
Barrett-Connor E, Khaw K-T. Cigarett smoking and increased endogenous estrogen levels in men. Am J Epidemiol 1987; 126: 187–92
Morley JE, Patrick P, Perry 3rd HM. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554–59
Acknowledgements
This study was supported by local funds from the University Hospital of North Norway.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Svartberg, J., Schirmer, H., Medbø, A. et al. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromsø Study. Eur J Epidemiol 22, 107–112 (2007). https://doi.org/10.1007/s10654-006-9095-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-006-9095-9